Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
| Title |
Grant Type |
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
Investigating the Value of Using Patient-Reported Outcomes in Oncology Patient Care
|
Research | Oncology | USA | |
Closing the HRRm Testing Gap in Prostate Cancer Patients
Release Date:
|
Quality Improvement | Oncology | Canada | |
Improving the care and outcomes of residents of Canada living with metastatic NSCLC
Release Date:
Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung Association
|
Quality Improvement | Oncology | Canada | |
Improving the Equity and Quality of Cancer Care in Colombia
Release Date:
Partner: The Colombian Association of Oncology and Hematology (ACHO)
|
Quality Improvement | Oncology | Colombia | |
Enhancing Molecular Testing for Metastatic Colorectal Cancer Patients
Release Date:
Partner: Colorectal Cancer Canada (CCC)
|
Quality Improvement | Oncology | Canada | |
Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial Infections
Release Date:
|
Education | Hospital | All | |
IBD QORUS HEALTH EQUITY REQUEST FOR APPLICATIONS (RFA)
Release Date:
Partner: Crohn's & Colitis Foundation
|
Quality Improvement | Inflammation & Immunology | USA | |
2024 Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Global Bridges at Mayo Clinic
|
Quality Improvement | Rare Disease | All | |
Junior Investigator Global ATTR Cardiac Amyloidosis Research
Release Date:
|
Research | Rare Disease | Australia, Canada, France, Germany, Italy, Japan, Korea, Spain | |
Reducing Barriers to Optimal Clinical Care in Breast Cancer
Release Date:
|
Quality Improvement | Oncology | Spain | |
Quality Improvement Grants to Improve Identification and Management of Patients with ATTR Amyloidosis
Release Date:
|
Quality Improvement | Rare Disease | Spain |
| Title |
Grant Type |
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
Pneumococcal Disease Prevention
Release Date:
|
||||
Chronic Pain
Release Date:
|
||||
Bacterial Infections
Release Date:
|
||||
Pharmacy Pneumococcal Disease Prevention
Release Date:
|
||||
Smoking Cessation
Release Date:
|
||||
Non-Small Cell Lung Cancer
Release Date:
|
||||
Cardiovascular Risk in Rheumatoid Arthritis
Release Date:
|
||||
Opioid Pain
Release Date:
|
||||
Adult Pneumococcal Disease Prevention
Release Date:
|
||||
Prevention of Stroke in Women
Release Date:
|
||||
Oncology Educational Needs Assessments
Release Date:
|
||||
Extension Grant
Release Date:
|